Unlearn.ai
AI-powered digital twins and scientific intelligence for faster, smarter clinical trials
Enterprise·Technical·Powered by Unlearn proprietary AI
Key strengths
AI-generated digital twins for patient outcome forecastingEMA-qualified methodology aligned with FDA guidanceIntegrated platform covering trial planning, monitoring, and analysisAutomated literature and regulatory precedent search (Scout)Measurable reductions in control arm size (~33%) and enrollment time (4+ months)
Enterprise pricing
US
Facts verified against unlearn.ai on
Get alerts when Unlearn.ai changes
Free. We'll email you when pricing, the free tier, API access or open-source status changes.
No ratings yet
Technical Use Cases
Unlearn is applicable across a range of clinical trial scenarios for pharmaceutical and biotech development teams:
| Use Case | Benefit |
|---|---|
| Trial Design Optimization | Reduce planned sample size by ~20% and control arm size by ~33% before enrollment begins |
| In-Progress Trial Augmentation | Apply digital twin modeling to ongoing trials to improve statistical power or reduce remaining enrollment burden |
| Post-Readout Analysis | Leverage digital twins after trial completion for additional analytical insights |
| Single-Arm Study Support | Augment trials without a traditional control arm using AI-generated patient comparators |
| Enrollment Timeline Reduction | Accelerate enrollment by 4+ months through reduced participant requirements |
Alternatives
See all alternatives Alternatives to Unlearn.ai
Is Unlearn.ai yours? Claim the listing & get the badge